Nandrolone Decanoate 250 mg/ml

Nandrolone Decanoate 250 mg/ml — Swiss Remedies

• Brand: Swiss Remedies
• Category: Injectable AAS · 19-nortestosterone derivative
• Content: 250 mg/ml nandrolone decanoate
• Packaging: 10 1 ml ampoules (250 mg per ampoule)
• Origin: Switzerland
• Note: For laboratory, forensic, and educational research only. Not for human or veterinary use.

Product Overview

Nandrolone Decanoate is a long-acting injectable anabolic-androgenic steroid (AAS) belonging to the 19-nortestosterone family.

It has been studied clinically for anaemia, severe muscle-wasting, osteoporosis, and chronic disease–related catabolism.

Modern research focuses on understanding nandrolone’s anabolic signalling, erythropoietic effects, PK/PD behaviour, and anti-doping detection.

The decanoate ester provides very slow release from the injection site, producing prolonged nandrolone exposure over 2–3 weeks after a single injection.

Nandrolone is a WADA S1 prohibited anabolic agent, banned in and out of competition.

Key Research Highlights

• Long-acting ester: Estimated elimination half-life ~6–12 days; functional duration 2–3 weeks.
• Anabolic profile: High anabolic effect relative to androgenic effect, though systemic risks remain.
• Clinical exploration: Studied for anaemia, osteoporosis, muscle wasting, and chronic disease catabolism.
• Erythropoietic action: Research shows increases in red blood cell mass and haemoglobin in specific patient models.
• Anti-doping: Fully banned; metabolites detectable long-term due to slow clearance.

Mechanism of Action

• Depot release: Decanoate ester slows absorption from the intramuscular site.
• Ester cleavage: Enzymatic hydrolysis releases active nandrolone.
• Androgen receptor activation: Promotes protein synthesis, nitrogen retention, and tissue repair signalling.
• Progestogenic activity: Contributes to HPG-axis suppression and sexual/reproductive side effects.

• Research & Clinical Context
• Anaemia: Historical studies showed improved haemoglobin and RBC mass in renal and chronic anaemia models.
• Bone health: Studied for improving bone mineral density in osteoporosis and corticosteroid-induced bone loss.
• Muscle wasting (cachexia): Research in chronic disease, HIV-associated wasting, and trauma-associated catabolism showed increases in lean mass.

Potential Effects Discussed in Literature (Not Recommendations)

• Enhanced nitrogen balance and muscle protein synthesis
• Increased lean body mass in catabolic conditions
• Improved bone mineral density in selected cohorts
• Increased haemoglobin and RBC mass

Limitations & Risks

• Suppression of natural testosterone and fertility
• Adverse lipid changes (HDL / LDL)
• Possible cardiovascular strain
• Progestogenic side effects (libido, erectile function changes)
• Prolonged detectability in doping tests

Safety, Side Effects & Risks

• HPG-axis suppression, testicular atrophy, infertility
• Virilisation in females (voice changes, hirsutism, clitoral enlargement)
• Acne, oily skin, hair loss in predisposed individuals
• Adverse cardiovascular markers (lipids, BP)
• Potential hepatic strain at high/prolonged exposure
• Mood changes, irritability, behavioural shifts
• Injection-site swelling, pain, or rare infection

Scientific Specifications

Field

Data

Active substance

Nandrolone Decanoate

Chemical family

19-nortestosterone derivative · AAS · Progestogen

Concentration

250 mg/ml

Dosage form

Oil-based injectable solution

Packaging

10 1 ml ampoules

Route (research context)

Intramuscular

Progestogenic activity

Yes — contributes to HPG suppression

Doping status

Prohibited at all times (WADA S1)

Country of manufacture

Switzerland

Compliance & Anti-Doping Notice

Nandrolone and its esters are controlled substances in many countries and are banned by WADA at all times.

Use is restricted to authorised laboratory and analytical research.

FOR RESEARCH USE ONLY — not a medicine, dietary supplement, or product for self-administration.